In head and neck squamous cell carcinoma, ALKBH5 inhibits RIG-1 expression and interferon-α production via the IKKε/TBK1/IRF3 pathway, thereby promoting tumor progression 32. This evidence concerns the gene ALKBH5 and neoplasm.